These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1832 related articles for article (PubMed ID: 35322324)

  • 1. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y; Gong P; Su L; Zhang M
    Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
    Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
    Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
    Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
    J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
    Li A; Hou S; Chen J; Jiang Y
    Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma.
    Zhang Q; Lv L; Ma P; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():743938. PubMed ID: 34956177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive exploration of immune checkpoint-related genes in the prognosis and tumor immune microenvironment of pancreatic adenocarcinoma.
    Chen X; Zhang H
    Clinics (Sao Paulo); 2024; 79():100481. PubMed ID: 39208654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
    Shi T; Gao G
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 16. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma.
    Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M
    Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.
    Deng J; Zhang Q; Lv L; Ma P; Zhang Y; Zhao N; Zhang Y
    Sci Rep; 2022 Apr; 12(1):7006. PubMed ID: 35488119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis.
    Ma J; Chen Z; Hou L
    Aging (Albany NY); 2024 Sep; 16(18):12525-12542. PubMed ID: 39332020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 92.